Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · IEX Real-Time Price · USD

1.305

+0.025 (1.95%)

At close: Jul 2, 2024, 4:00 PM

1.310

+0.005 (0.38%)

After-hours: Jul 2, 2024, 5:53 PM EDT

Spero Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Net Income	22.81	-46.42	-89.76	-78.28	-60.93	Upgrade
Depreciation & Amortization	0.37	0.87	0.65	0.76	0.75	Upgrade
Share-Based Compensation	7.93	9.12	9.43	4.89	3.78	Upgrade
Other Operating Activities	-64.1	28.69	15.33	-13.24	6.38	Upgrade
Operating Cash Flow	-33	-7.73	-64.35	-85.87	-50.02	Upgrade
Capital Expenditures	0	0	0	0	-0.31	Upgrade
Change in Investments	0	33.81	7.63	10.63	29.84	Upgrade
Other Investing Activities	-	-	0.04	-0.16	-	Upgrade
Investing Cash Flow	0	33.81	7.67	10.47	29.53	Upgrade
Share Issuance / Repurchase	0.22	24.93	36.82	80.85	16.3	Upgrade
Debt Issued / Paid	0	-54.49	0	0	0	Upgrade
Other Financing Activities	-	-	47.23	50.03	-0.16	Upgrade
Financing Cash Flow	0.22	-29.55	84.05	130.88	16.14	Upgrade
Net Cash Flow	-32.77	-3.48	27.38	55.48	-4.35	Upgrade
Free Cash Flow	-33	-7.73	-64.35	-85.87	-50.33	Upgrade
Free Cash Flow Margin	-31.79%	-14.45%	-352.47%	-920.39%	-277.37%	Upgrade
Free Cash Flow Per Share	-0.63	-0.21	-2.08	-3.84	-2.77	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).